-
Why 5 Of 6 UnitedHealth Analysts Are Cutting Forecasts After Q3 Earnings Release
Wednesday, October 16, 2024 - 12:18pm | 967Read More...UnitedHealth Group Inc (NYSE:UNH) reported on Tuesday upbeat earnings for its third quarter. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. RBC Capital Markets On UnitedHealth Group Analyst Ben Hendrix reiterated an Outperform rating while...
-
UnitedHealth Reports 'Noisy' Quarterly Results: 5 Analysts Weigh In On 'Compelling Levers Of Improvement' For 2025
Wednesday, July 17, 2024 - 3:05pm | 679Read More...Shares of UnitedHealth Group Inc (NYSE:UNH) were climbing in early trading on Wednesday, after the company reported its second-quarter results. The results came amid an exciting earnings season. Here are some key analyst takeaways. RBC Capital Markets analyst Ben Hendrix reiterated an Outperform...
-
HCA Healthcare Price Estimates Raised On Strong Performance And Optimistic Outlook
Monday, April 24, 2023 - 11:16am | 561Read More...Shares of HCA Healthcare Inc (NYSE: HCA) continued to climb in early trading on Monday, after smashing earnings expectations and getting price targets bumped by analysts. Here are some key takeaways from additional analysts. Oppenheimer On HCA Healthcare Analyst Michael Wiederhorn maintained an...
-
Oppenheimer Joins Chorus Of CVS Analysts Cautious On Near-Term Outlook
Monday, April 15, 2019 - 10:19am | 403Read More...Less than a week after BMO Capital Markets downgraded CVS Health Corp (NYSE: CVS), Oppenheimer is stepping to the sidelines. The Analyst Analyst Michael Wiederhorn downgraded CVS from Outperform to Perform and removed the $85 price target. The Thesis CVS is more of a long-term...
-
Sell-Side Takes Community Health's Vital Signs After Sickly Q2 Preview Release
Thursday, July 27, 2017 - 2:02pm | 347Read More...One bull still stands for Community Health Systems (NYSE: CYH), even after management’s preview of second-quarter earnings on Wednesday shocked and disappointed most investors. The news also came just a day after HCA Healthcare Inc (NYSE: HCA) reported a miss for Q2 and EPS guidance for the...
-
In The Wake Of Failed Merger With Aetna, Humana Regains Outperform Rating From Oppenheimer
Thursday, March 30, 2017 - 1:43pm | 458Read More...In a note released on Thursday, Oppenheimer said it is reinstating an Outperform rating on Humana Inc (NYSE: HUM), attributing the move to the termination of the company's merger with Aetna Inc (NYSE: AET). The firm has a 12–18-month price target of $236 for the company. The firm presented...
-
Oppenheimer Upgrades Amedisys To Outperform, Sets $40 Target
Monday, February 8, 2016 - 3:43pm | 252Read More...Oppenheimer on Monday issued a report on Amedisys Inc (NASDAQ: AMED) amid signs that the company may be undervalued. The firm upgraded Amedisys from Perform to Outperform and issued a $40 price target. Analysts Michael Wiederhorn and Matt Nirenberg wrote, "We are upgrading the shares of...
-
35 Stock Ideas Oppenheimer Analysts Love Right Now
Saturday, October 17, 2015 - 10:11pm | 1463Read More...Oppenheimer just released its 35 top stock ideas for October and November. Here’s a rundown of the full list with analyst commentary included. 1. Turtle Beach Corp (NASDAQ: HEAR) Analyst Sean McGowan sees two drivers of the stock: the “resurgence in video games” and the rollout of...
-
Oppenheimer Boosts Hospital Price Targets Following Obamacare Decision
Friday, June 26, 2015 - 9:39am | 262Read More...Following the Supreme Court's decision on Thursday to reaffirm the Affordable Care Act, also known as Obamacare, analysts at Oppenheimer increased their price target on HCA Holdings Inc (NYSE: HCA) and Community Health Systems (NYSE: CYH). Oppenheimer's Michael Wiederhorn hiked...
-
8 Oppenheimer Analysts Choose Their Favorite Healthcare Stocks
Tuesday, March 31, 2015 - 12:04pm | 463Read More...In a recent report, Oppenheimer asked analysts that cover different areas of the stock market each to choose his or her single top stock pick in the space based on the company's fundamentals. Here are the stocks that Oppenheimer's eight analysts in the healthcare sector chose as top...
-
UPDATE: Oppenheimer Initiates Coverage on Envision Healthcare on Premier Operator Position
Monday, September 23, 2013 - 11:21am | 151Read More...In a report published Monday, Oppenheimer analyst Michael Wiederhorn initiated coverage on Envision Healthcare Holdings (NYSE: EVHC) with an Outperform rating and $33.00 price target. In the report, Oppenheimer noted, “We are initiating coverage of Envision Healthcare with an Outperform rating and...
-
UPDATE: Oppenheimer Raises PT on The Ensign Group Following Management Meetings
Thursday, September 12, 2013 - 10:18am | 149Read More...In a report published Thursday, Oppenheimer analyst Michael Wiederhorn reiterated an Outperform rating on The Ensign Group (NASDAQ: ENSG), and raised the price target from $44.00 to $46.00. In the report, Oppenheimer noted, “Following meetings with mgmt, we believe ENSG remains well-positioned to...
-
UPDATE: Oppenheimer Raises PT on Centene Corp Citing Strong 2Q13 Results
Wednesday, July 24, 2013 - 8:35am | 85Read More...In a report published on Wednesday, Oppenheimer analyst Michael Wiederhorn reiterated an Outperform rating on Centene (NYSE: CNC) and increased the price target from $55 to $65. In the report, Oppenheimer noted, "Overall, CNC continues to rebound, with robust growth and further margin traction...
-
Oppenheimer Reiterates Air Methods (AIRM) Outperform Rating
Friday, March 12, 2010 - 10:31am | 104Read More...Oppenheimer analysts Michael Wiederhorn, Matt Nirenberg and Jeffrey Fedder reiterated their Outperform rating for shares of Air Methods Corporation (Nasdaq: AIRM), with a price target of $38. The analysts believe that Air Methods Corporation's disappointing results were due to poor weather...
